Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract

Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS™ Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors